Lay summary
Weaning is a stressful stage for young pigs and is often associated with digestive problems such as diarrhea, which can impair growth and feed efficiency. These issues are commonly linked to harmful gut bacteria, including Escherichia coli...
Lay summary
Weaning is a stressful stage for young pigs and is often associated with digestive problems such as diarrhea, which can impair growth and feed efficiency. These issues are commonly linked to harmful gut bacteria, including Escherichia coli, Salmonella, and Clostridium perfringens. Meanwhile, increasing restrictions on antibiotic use in many countries, including South Korea, have highlighted the need for safe and effective alternatives. This study examined whether dietary supplementation with a bacteriophage—viruses that specifically target harmful bacteria—could improve growth, digestion, and gut health in weaning pigs under normal conditions. A total of 160 weaning pigs were fed diets containing different levels of bacteriophages for five weeks. Pigs receiving bacteriophages showed improved growth, particularly during the later weaning period. Feed efficiency improved early after weaning without increased feed intake, indicating more efficient feed utilization. Nutrient digestibility tended to improve, and fecal moisture content decreased, suggesting firmer stools and a lower risk of diarrhea. While overall gut bacterial diversity remained unchanged, the microbial community structure shifted over time, with reductions in bacteria associated with gut imbalance and increases in beneficial bacteria at higher bacteriophage levels.
Overall, these findings indicate that dietary bacteriophages can support healthy growth and gut function in weaning pigs and represent a promising antibiotic-free strategy to help manage weaning-related digestive challenges.
Abstract
Weaning is one of the most challenging events in a pig’s life and is often associated with disturbances in intestinal integrity and immune function, which impair health status, growth performance, and feed intake (Campbell et al., 2013). During this period, weaning pigs commonly suffer from post-weaning diarrhea syndrome (PWD), a multifactorial condition characterized by impaired intestinal function (van Beers‐Schreurs, 1992; Gao et al., 2019; Eriksen et al., 2021).
The occurrence of PWD has been largely attributed to the presence and proliferation of enterotoxigenic Escherichia coli (ETEC), which is considered a primary causative agent (Eriksen et al., 2021; Rhouma et al., 2017; Luppi, 2017). In addition to ETEC, other microbial agents have been implicated in the onset and severity of PWD. Along with ETEC, Salmonella spp. are recognized as important pathogens affecting the health of weaning pigs and are associated with diarrheal disorders during the post-weaning period (Song et al., 2025). Furthermore, Clostridium perfringens, although a commensal member of the porcine gut microbiota, may contribute to intestinal disturbances and diarrhea under certain conditions.
Antibiotics have historically been employed in the livestock industry to control such pathogenic microorganisms. In particular, antibiotic growth promoters (AGPs), which involve the continuous inclusion of low-dose antibiotics in feed to improve growth performance, feed efficiency, and diarrhea incidence, have been widely used in swine production. However, prolonged antibiotic use has raised concerns regarding environmental contamination, antibiotic residues in livestock products, and the emergence of antimicrobial resistance (Zaheer et al., 2013; Saraiva et al., 2022). Consequently, the European Union initiated restrictions on AGPs with the ban of avoparcin in 1997 and implemented a complete prohibition on the use of antibiotics in animal feed by 2006, while South Korea banned the use of AGPs in 2011. Therefore, there is a need to develop alternative to antibiotics, which support growth performance in the absence of antibiotics.
Among various antibiotic alternatives, bacteriophages—viruses that infect and lyse bacteria—have gained increasing attention. In studies involving animals challenged with pathogenic infections, bacteriophage supplementation has been shown to exert therapeutic effects by reducing pathogen load and alleviating disease symptoms (Wall et al., 2010; Jamalludeen et al., 2009; Atterbury et al., 2009). In addition, Kim (2014) reported improved growth performance in unchallenged barrows supplemented with bacteriophages.
Nevertheless, despite these findings, the effects of bacteriophage supplementation under normal, unchallenged conditions remain unclear. For example, Han et al. (2016) reported that fecal concentrations of E. coli K99 did not differ significantly between phage-treated and untreated pigs throughout the sampling period (1, 3, and 7 d post-challenge; P > 0.05). These inconsistent results suggest that responses to bacteriophage supplementation may depend on animal health status and microbial pressure.
Therefore, the present study was conducted to evaluate the effects of dietary bacteriophage supplementation on growth performance and fecal microbiome in unchallenged pigs.